We are initiating coverage of Resverlogix Corp. (RVX.TO) (RVXCF) with a "Hold" rating and a $3.25 price target. Resverlogix Corp. is a clinical stage cardiovascular company with an epigenetic platform ...
MUNICH and CALGARY, Aug. 28, 2012 /PRNewswire/ - Resverlogix Corp. (TSX: RVX) today announced that the BET protein inhibitor RVX-208 significantly increased HDL-C (p=0.001), the primary endpoint of ...
Resverlogix Corp. Annual stock financials by MarketWatch. View the latest RVX financial statements, income statements and financial ratios.
Our first exposure to the Klipsch RVX-54 Home Theater Speaker System came while touring the sea of electronics on the convention floor at the 2005 Consumer Electronics Show (CES) in Las Vegas. In a ...
Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients ...
The new RVX show may have been formed with the goal of attracting new, adventurous buyers (the crossover utility vehicle set, if you will), but it was still a sea of huge, lumbering mobile homes that ...
Big RVs still rule the American market, but there's been some measurable movement toward more compact camping and travel, with some innovative camper vans launching in hopes of keeping that movement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback